{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:28:32Z","timestamp":1778632112495,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.pharep.2014.04.003","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T20:30:11Z","timestamp":1398112211000},"page":"691-698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Nitroxyl inhibits overt pain-like behavior in mice: Role of cGMP\/PKG\/ATP-sensitive potassium channel signaling pathway"],"prefix":"10.1007","volume":"66","author":[{"given":"Larissa","family":"Staurengo-Ferrari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Zarpelon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela T.","family":"Longhi-Balbinot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago M.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 C.","family":"Alves-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Q.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio H.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubia","family":"Casagrande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina M.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-9283","authenticated-orcid":false,"suffix":"Jr","given":"Waldiceu A.","family":"Verri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"2","key":"10.1016\/j.pharep.2014.04.003_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.pharep.2014.04.003_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0896-6273(92)90104-L","article-title":"Nitric oxide: a novel neuronal messenger","volume":"8","author":"Bredt","year":"1992","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.pharep.2014.04.003_bib0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0166-2236(92)90021-Y","article-title":"Neurons that say NO","volume":"15","author":"Vincent","year":"1992","journal-title":"Trends Neurosci"},{"issue":"Suppl. 1","key":"10.1016\/j.pharep.2014.04.003_bib0020","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1038\/sj.bjp.0706458","article-title":"The discovery of nitric oxide and its role in vascular biology","volume":"147","author":"Moncada","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharep.2014.04.003_bib0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.niox.2011.06.004","article-title":"Pain and analgesia: the dual effect of nitric oxide in the nociceptive system","volume":"25","author":"Cury","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.pharep.2014.04.003_bib0030","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signalling molecule in the nervous system","volume":"135","author":"Esplugues","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2014.04.003_bib0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.niox.2010.12.010","article-title":"Interactions between nitric oxide and hypoxia inducible factor signaling pathways in inflammatory disease","volume":"25","author":"Olson","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.pharep.2014.04.003_bib0040","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3390\/ijms11072715","article-title":"Nitric oxide: perspectives and emerging studies of a well known cytotoxin","volume":"11","author":"Paradise","year":"2010","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharep.2014.04.003_bib0045","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1073\/pnas.0914733107","article-title":"Morphine peripheral analgesia depends on activation of the PI3Kgamma\/AKT\/nNOS\/NO\/KATP signaling pathway","volume":"107","author":"Cunha","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharep.2014.04.003_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(01)01995-3","article-title":"The dual effect of a nitric oxide donor in nociception","volume":"897","author":"Sousa","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2014.04.003_bib0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(92)90159-2","article-title":"Antinociceptive effect of L-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opioidergic systems","volume":"218","author":"Kawabata","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2014.04.003_bib0060","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.bjp.0704755","article-title":"Dual effect of nitric oxide in articular inflammatory pain in zymosan-induced arthritis in rats","volume":"136","author":"Rocha","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2014.04.003_bib0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-2999(92)90881-4","article-title":"Analgesia by direct antagonism of nociceptor sensitization involves the arginine nitric oxide cGMP pathway","volume":"217","author":"Duarte","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2014.04.003_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2004.09.018","article-title":"Peripheral involvement of the nitric oxide-cGMP pathway in the indomethacin-induced antinociception in rat","volume":"503","author":"Ventura-Martinez","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2014.04.003_bib0075","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1073\/pnas.0308382101","article-title":"Peripheral analgesic blockade of hypernociception: activation of arginine\/NO\/cGMP\/protein kinase G\/ATPsensitive K+ channel pathway","volume":"101","author":"Sachs","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.pharep.2014.04.003_bib0080","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/np200989t","article-title":"Kaurenoic acid from Sphagneticola trilobata inhibits inflammatory pain: effect on cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway","volume":"75","author":"Mizokami","year":"2012","journal-title":"J Nat Prod"},{"issue":"1","key":"10.1016\/j.pharep.2014.04.003_bib0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.bjp.0706836","article-title":"Atorvastatin inhibits inflammatory hypernociception","volume":"149","author":"Santodomingo-Garzon","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2014.04.003_bib0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00011-006-6109-8","article-title":"Role of NO\/cGMP\/KATP pathway in antinociceptive effect of sildenafil in zymosan writhing response in mice","volume":"56","author":"Vale","year":"2007","journal-title":"Inflamm Res"},{"issue":"12","key":"10.1016\/j.pharep.2014.04.003_bib0095","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tips.2008.08.005","article-title":"Nitroxyl (HNO): the Cinderella of the nitric oxide story","volume":"29","author":"Irvine","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharep.2014.04.003_bib0100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0006-2952(92)90584-6","article-title":"Chemical oxidation of N-hydroxyguanidine compounds. Release of nitric oxide, nitroxyl and possible relationship to the mechanism of biological nitric oxide generation","volume":"43","author":"Fukuto","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharep.2014.04.003_bib0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.pharmtox.45.120403.095959","article-title":"Nitroxyl (HNO): chemistry, biochemistry, and pharmacology","volume":"45","author":"Fukuto","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"10.1016\/j.pharep.2014.04.003_bib0110","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.freeradbiomed.2005.10.058","article-title":"Discriminating formation of HNO from other reactive nitrogen oxide species","volume":"40","author":"Donzelli","year":"2006","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.pharep.2014.04.003_bib0115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.freeradbiomed.2008.04.036","article-title":"Generation of nitroxyl by heme protein-mediated peroxidation of hydroxylamine but not N-hydroxy-L-arginin","volume":"45","author":"Donzelli","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharep.2014.04.003_bib0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0891-5849(02)01179-6","article-title":"Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning","volume":"34","author":"Pagliaro","year":"2003","journal-title":"Free Radic Bio Med"},{"key":"10.1016\/j.pharep.2014.04.003_bib0125","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/01.HYP.0000072010.54901.DE","article-title":"NO\u2212 activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries","volume":"41","author":"Irvine","year":"2003","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.pharep.2014.04.003_bib0130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1476-5381.2009.00150.x","article-title":"A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries","volume":"157","author":"Andrews","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2014.04.003_bib0135","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/ic50145a022","article-title":"Thermal decomposition of oxyhyponitrite (sodium trioxodinitrate (II) in aqueous solution","volume":"14","author":"Bonner","year":"1975","journal-title":"Inorg Chem"},{"key":"10.1016\/j.pharep.2014.04.003_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.03.009","article-title":"The nitroxyl donor, Angeli's salt, inhibits inflammatory hyperalgesia in rats","volume":"71","author":"Zarpelon","year":"2013","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pharep.2014.04.003_bib0145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1476-5381.1968.tb00973.x","article-title":"The abdominal constriction response and its suppression by analgesic drugs in the mouse","volume":"32","author":"Collier","year":"1968","journal-title":"Br J Pharmacol Chemother"},{"issue":"2","key":"10.1016\/j.pharep.2014.04.003_bib0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0304-3959(77)90130-0","article-title":"The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats","volume":"4","author":"Dubuisson","year":"1977","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharep.2014.04.003_bib0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2006.04.001","article-title":"Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?","volume":"112","author":"Verri","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharep.2014.04.003_bib0160","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1021\/ja01506a043","article-title":"The alleged role of nitroxyl in certain reactions of aldehydes and alkyl halides","volume":"82","author":"Smith","year":"1960","journal-title":"J Am Chem Soc"},{"issue":"11","key":"10.1016\/j.pharep.2014.04.003_bib0165","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1021\/jm00115a013","article-title":"Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects","volume":"34","author":"Maragos","year":"1991","journal-title":"J Med Chem"},{"issue":"2\u20133","key":"10.1016\/j.pharep.2014.04.003_bib0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2008.04.010","article-title":"Role of IL-18 in overt pain-like behaviour in mice","author":"Verri","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharep.2014.04.003_bib0175","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pbb.2012.01.018","article-title":"Acetic acid and phenyl-p-benzoquinone-induced overt pain-like behavior depends on spinal activation of MAP kinases: PI(3)K and microglia in mice","volume":"101","author":"Pavao-de-Souza","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"issue":"2\u20133","key":"10.1016\/j.pharep.2014.04.003_bib0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-2999(94)90398-0","article-title":"Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization","volume":"251","author":"Tonussi","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.pharep.2014.04.003_bib0185","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1021\/np900259y","article-title":"Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production","volume":"72","author":"Valerio","year":"2009","journal-title":"J Nat Prod"},{"issue":"1","key":"10.1016\/j.pharep.2014.04.003_bib0190","first-page":"99","article-title":"Analgesic activity of namoxyrate (2-[4-biphenylylbutyric acid 2-dimethylaminoethanol salt)","volume":"170","author":"Emele","year":"1967","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharep.2014.04.003_bib0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pbb.2013.02.006","article-title":"The ruthenium NO donor, [Ru(bpy)2(NO)SO3](PF6), inhibits inflammatory pain: involvement of TRPV1 and cGMP\/PKG\/ATP-sensitive potassium channel signaling pathway","volume":"105C","author":"Staurengo-Ferrari","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2014.04.003_bib0200","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pharmthera.2006.11.002","article-title":"The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the janus face of NO","volume":"113","author":"Paolocci","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharep.2014.04.003_bib0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-2999(99)00790-6","article-title":"Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice","volume":"387","author":"Ribeiro","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2014.04.003_bib0210","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jep.2009.01.031","article-title":"Antinociceptive activity of Amaranthus spinosus in experimental animals","volume":"122","author":"Zeashan","year":"2009","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharep.2014.04.003_bib0215","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0306-4522(00)00523-6","article-title":"The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception","volume":"102","author":"Parada","year":"2001","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.pharep.2014.04.003_bib0220","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.bjp.0705724","article-title":"Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats","volume":"141","author":"Chichorro","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharep.2014.04.003_bib0225","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cardiores.2006.11.018","article-title":"The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature","volume":"73","author":"Favaloro","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.pharep.2014.04.003_bib0230","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.HYP.0000259328.04159.90","article-title":"Nitroxyl anion donor: Angeli's salt, does not develop tolerance in rat-isolated aortae","volume":"49","author":"Irvine","year":"2007","journal-title":"Hypertension"},{"issue":"33","key":"10.1016\/j.pharep.2014.04.003_bib0235","doi-asserted-by":"crossref","first-page":"21788","DOI":"10.1074\/jbc.M109.014282","article-title":"The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols","volume":"284","author":"Miller","year":"2009","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharep.2014.04.003_bib0240","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1124\/mol.109.059915","article-title":"Mechanisms underlying activation of soluble guanylate cyclase by the nitroxyl donor Angeli's salt","volume":"76","author":"Zeller","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.pharep.2014.04.003_bib0245","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1124\/jpet.103.064154","article-title":"A newly identified role for superoxide in inflammatory pain","volume":"309","author":"Wang","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.pharep.2014.04.003_bib0250","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/sj.bjp.0701940","article-title":"Nitric oxide (NO)-induced activation of large conductance Ca2+-dependent K+ channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery","volume":"124","author":"Mistry","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2014.04.003_bib0255","first-page":"101","article-title":"Molecular base of acetylcholine and morphine analgesia","volume":"32","author":"Ferreira","year":"1991","journal-title":"Agents Actions Suppl"},{"issue":"1\u20133","key":"10.1016\/j.pharep.2014.04.003_bib0260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2012.04.009","article-title":"The inhibition of the nitric oxide-cGMP-PKG-JNK signaling pathway avoids the development of tolerance to the local antiallodynic effects produced by morphine during neuropathic pain","volume":"685","author":"Hervera","year":"2012","journal-title":"Eur J Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:29Z","timestamp":1752611729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2014.04.003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1734114014001467"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2014.04.003","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitroxyl inhibits overt pain-like behavior in mice: Role of cGMP\/PKG\/ATP-sensitive potassium channel signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2014.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}